TY - JOUR
T1 - Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish heart health extended cohort study
AU - Juraschek, Stephen P.
AU - Tunstall-Pedoe, Hugh
AU - Woodward, Mark
N1 - Funding Information:
SPJ was supported by the NIH/NHLBI , T32HL007024 Cardiovascular Epidemiology Training Grant .
PY - 2014/4
Y1 - 2014/4
N2 - Background: Elevated uric acid is a prevalent condition with controversial health consequences. Observational studies disagree with regard to the relationship of uric acid with mortality, and with factors modifying this relationship. Objective: We examined the association of serum uric acid with mortality in 15,083 participants in the Scottish Heart Health Extended Cohort (SHHEC) Study. Methods: Serum uric acid was measured at study enrollment. Death was ascertained using both the Scottish death register and record linkage. Results: During a median follow-up of 23 years, there were 3980 deaths. In Cox proportional hazards models with sexes combined, those in the highest fifth of uric acid had significantly greater mortality (HR 1.18, 95% CI: 1.06, 1.31) compared with the second fifth, after adjustment for traditional cardiovascular risk factors. This relationship was modified by sex (P-interaction=0.002) with adjusted HRs of 1.69 (95% CI: 1.40, 2.04) and 0.99 (95% CI: 0.86, 1.14) in women and men, respectively. Compared with the second fifth, the highest fifth of uric acid was most associated with kidney-related death (HR: 2.08, 95% CI: 1.31, 3.32). Conclusion: Elevated uric acid is associated with earlier mortality, especially in women. Future studies should evaluate mechanisms for these interactions and explore the strong association with renal-related mortality.
AB - Background: Elevated uric acid is a prevalent condition with controversial health consequences. Observational studies disagree with regard to the relationship of uric acid with mortality, and with factors modifying this relationship. Objective: We examined the association of serum uric acid with mortality in 15,083 participants in the Scottish Heart Health Extended Cohort (SHHEC) Study. Methods: Serum uric acid was measured at study enrollment. Death was ascertained using both the Scottish death register and record linkage. Results: During a median follow-up of 23 years, there were 3980 deaths. In Cox proportional hazards models with sexes combined, those in the highest fifth of uric acid had significantly greater mortality (HR 1.18, 95% CI: 1.06, 1.31) compared with the second fifth, after adjustment for traditional cardiovascular risk factors. This relationship was modified by sex (P-interaction=0.002) with adjusted HRs of 1.69 (95% CI: 1.40, 2.04) and 0.99 (95% CI: 0.86, 1.14) in women and men, respectively. Compared with the second fifth, the highest fifth of uric acid was most associated with kidney-related death (HR: 2.08, 95% CI: 1.31, 3.32). Conclusion: Elevated uric acid is associated with earlier mortality, especially in women. Future studies should evaluate mechanisms for these interactions and explore the strong association with renal-related mortality.
KW - Cancer
KW - Cardiovascular disease
KW - Cohort
KW - Hyperuricemia
KW - Kidney disease
KW - Mortality
KW - Scottish heart health extended cohort (SHHEC)
KW - Uric acid
UR - http://www.scopus.com/inward/record.url?scp=84896285653&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896285653&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2014.01.026
DO - 10.1016/j.atherosclerosis.2014.01.026
M3 - Article
C2 - 24534458
AN - SCOPUS:84896285653
SN - 0021-9150
VL - 233
SP - 623
EP - 629
JO - Atherosclerosis
JF - Atherosclerosis
IS - 2
ER -